Understanding the Increased Risk of Atrial Fibrillation in Athletes: a Case-control Study
NCT ID: NCT06844656
Last Updated: 2025-02-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
200 participants
OBSERVATIONAL
2025-02-28
2026-10-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The mechanisms behind this increased risk of atrial fibrillation are not the well understood. It is thought to be a mixture of enlarged heart chambers, low resting heart rate, genetic predisposition and possibly scarring in the heart. In this study, the investigators will investigate the electrical activity changes in the heart, using a high-quality electrocardiogram (ECG) and relate this to changes in the heart size measured by ultrasound and MRI. Cardiopulmonary exercise testing will determine fitness (V̇O2 max) and assess the heart's electrical activity during exercise.
This will be a case-control study where athletes with and without atrial fibrillation will be recruited. The investigators hope the results of this study can improve our understanding of atrial fibrillation in athletes by associating atrial fibrillation with structural and electrical differences which may aid the prediction of future atrial fibrillation development and help guide more athlete-specific treatment pathways.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Exercise Training in Patients With Permanent Atrial Fibrillation
NCT01721863
Effects of Detraining in Endurance Athletes With Atrial Fibrillation
NCT04991337
Concurrent Training in Patients Undergoing Atrial Fibrillation Ablation.
NCT06832033
Detraining on Atrial Fibrillation
NCT03642886
Atrial Electromechanical Function in Endurance Athletes With and Without Atrial Fibrillation
NCT03305744
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AF Athletes
Athletes with atrial fibrillation.
No interventions assigned to this group
Non-AF Athletes
Athletes without atrial fibrillation.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* History of atrial fibrillation confirmed on ECG - either paroxysmal or persistent.
* Competitive athlete. Defined as:
1. Competed in endurance sports with a total cumulative moderate to high intensity of \> 1500 hours.
2. Have participated in at least one competitive event in the last 10 years.
Exclusion Criteria
* History of pre-existing cardiovascular disease :
1. Atherosclerotic disease: previous myocardial infarction, symptomatic coronary artery disease or Peripheral peripheral arterial disease
2. Left ventricular systolic dysfunction (EF \< 45%)
3. Heart muscle disease: cardiomyopathies, Infiltrative diseases of the heart
4. Complex Congenital heart disease
5. Moderate or severe valvular disease
6. Uncontrolled hypertension (\>180/100mmHg)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Leicester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Cardiovascular Sciences. University of Leicester. Glenfield Hospital.
Leicester, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.